Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
271 studies found for:    Open Studies | "Edema"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Edema"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Conditions: Macular Edema;   Cystoid Macular Edema;   Uveal Melanoma;   Radiation Maculopathy;   Radiation Retinopathy
Interventions: Drug: Ozurdex;   Drug: Bevacizumab
2 Recruiting Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
Conditions: Diabetes;   Diabetic Macular Oedema;   Diabetic Macular Edema;   Diabetic Retinopathy
Interventions: Drug: Avastin (Bevacizumab);   Drug: Ozurdex (dexamethasone)
3 Unknown  A Multicenter, Double-blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
Condition: Cardiac-induced Edema
Interventions: Drug: Tolvaptan;   Drug: Placebo
4 Unknown  Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
Conditions: Corneal Edema;   Visual Acuity
Interventions: Drug: Brimonidine Tartrate 0.2%;   Drug: Timolol maleate 0.5%
5 Unknown  Study of Idiopathic Edema
Condition: Idiopathic Edema Nocturia
Intervention:
6 Not yet recruiting Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema
Condition: Diabetic Macular Oedema
Intervention: Device: Ellex Integre NIR  laser
7 Not yet recruiting Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: bevacizumab;   Device: PASCAL Endpoint Management (EpM) laser treatment
8 Recruiting A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Condition: Macular Edema, Diabetic
Interventions: Drug: Ranibizumab;   Drug: Placebo;   Drug: PF-04634817;   Drug: Masked Sham Therapy
9 Recruiting The Intraocular Pressure Measured by Different Tonometers in Corneal Edema
Conditions: Intraocular Pressure;   Corneal Edema
Intervention: Other: Intraocular pressure measurement
10 Unknown  Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Bevacizumab intravitreal;   Drug: Triamcinolone;   Drug: Triamcinolone + Bevacizumab
11 Unknown  Micropulse 577 nm Laser Photocoagulation Versus Conventional 532 nm Laser Photocoagulation for Diabetic Macular Oedema
Condition: Diabetic Macular Edema
Interventions: Device: Micropulse 577 nm yellow diode laser;   Device: 532 nm green diode laser
12 Unknown  Power Spectral Analysis of Breath Sound in Pulmonary Edema
Condition: Pulmonary Edema
Intervention:
13 Recruiting Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
Conditions: Branch Retinal Vein Occlusion;   Macular Edema
Interventions: Drug: Ranibizumab;   Device: Sham injection;   Procedure: Rescue laser
14 Unknown  Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
Conditions: Traumatic Brain Injury;   Subdural Hematoma;   Cerebral Contusion;   Head Injury;   Cerebral Edema
Interventions: Drug: Induced, sustained hypernatremia using hypertonic saline;   Drug: Standard of care (hypertonic saline and mannitol; serum sodium)
15 Unknown  Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
Conditions: Macular Edema;   Central Retinal Vein Occlusion
Intervention: Drug: bevacizumab and triamcinolone
16 Recruiting Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
Conditions: Macular Edema;   Branch Retinal Vein Occlusion;   Central Retinal Vein Occlusion
Intervention: Drug: ranibizumab
17 Unknown  Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Triamcinolone Acetonide 4 mg intravitreal injection;   Procedure: ETDRS grid laser technique
18 Recruiting Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
19 Recruiting Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
Conditions: Diabetic Retinopathy;   Macular Edema
Interventions: Drug: Tromethamine ketorolac;   Drug: Nepafenac;   Drug: Polietilenglicol 400, propilenglicol, HP guar
20 Unknown  Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Conditions: Diabetic Macular Edema.;   Non-proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Interventions: Drug: dexamethasone intravitreal implant;   Drug: intravitreal bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years